What is MindMaze Therapeutics Holding Days Payable?
MindMaze Therapeutics HoldingCHIX:MMTXZ +4.74%15 Days Payable is 7,682.89 as of Dec. 2025, which is at its 10-year median of 7,682.89. GuruFocus rates CHIX:MMTXZ with a GF Score™ of 15/100. The stock has 2 warning signs investors should review. Among 703 Biotechnology companies, MindMaze Therapeutics Holding ranks better than 95.16% on this metric.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MindMaze Therapeutics Holding Days Payable Chart
MindMaze Therapeutics Holding Annual Data
Trend
Dec24
Dec25
Days Payable
0.00
7,682.89
MindMaze Therapeutics Holding Semi-Annual Data
Dec24
Dec25
Days Payable
0.00
7,682.89
CHIX:MMTXZ vs VRTX, REGN, ALNY: Days Payable Comparison
For the Biotechnology subindustry, MindMaze Therapeutics Holding's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
MindMaze Therapeutics Holding Days Payable vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, MindMaze Therapeutics Holding's Days Payable distribution charts can be found below:
* The bar in red indicates where MindMaze Therapeutics Holding's Days Payable falls into.
MindMaze Therapeutics Holding Days Payable Calculation
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MindMaze Therapeutics Holding (CHIX:MMTXZ) has a Days Payable of 7,682.89 as of Dec. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on MindMaze Therapeutics Holding and its competitors. This is near median its historical median of 7,682.89. Over the past decade, MindMaze Therapeutics Holding's Days Payable has ranged from 7,682.89 to 7,682.89. According to the industry distribution chart, MindMaze Therapeutics Holding ranks #34 out of 703 companies in the Biotechnology industry, placing it in the top 4.8%.
Is MindMaze Therapeutics Holding's Days Payable too high?
MindMaze Therapeutics Holding's current Days Payable of 7,682.89 is near median its 10-year median of 7,682.89. Over the past 10 years, this metric has ranged from a low of 7,682.89 to a high of 7,682.89. The Biotechnology industry median Days Payable is 113.76. MindMaze Therapeutics Holding's value of 7,682.89 is 6653.6% above this industry median. Based on the distribution chart, MindMaze Therapeutics Holding ranks #34 out of 703 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, MindMaze Therapeutics Holding has a GF Score™ of 15/100, reflecting its overall financial health beyond just this single metric.
How does MindMaze Therapeutics Holding's Days Payable compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, MindMaze Therapeutics Holding ranks #34 out of 703 companies for Days Payable. This places MindMaze Therapeutics Holding in the top 5% of its industry — outperforming the majority of peers. The industry median Days Payable is 113.76. MindMaze Therapeutics Holding's value of 7,682.89 is 6653.6% above this benchmark. Historically, MindMaze Therapeutics Holding's own Days Payable has ranged from 7,682.89 to 7,682.89 over the past decade. While the company's 10-year median is 7,682.89 vs. the industry median of 113.76, MindMaze Therapeutics Holding has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Biotechnology company?
The median Days Payable among Biotechnology companies is 113.76, based on 703 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. MindMaze Therapeutics Holding's current Days Payable of 7,682.89 is 6653.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on MindMaze Therapeutics Holding and its competitors. For the Biotechnology industry, the median Days Payable is 113.76 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. MindMaze Therapeutics Holding's current Days Payable is 7,682.89, which is near median its own 10-year median of 7,682.89. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MindMaze Therapeutics Holding stock overvalued right now?
MindMaze Therapeutics Holding (CHIX:MMTXZ) has a current Days Payable of 7,682.89. The current Days Payable is 7,682.89, which is near median its 10-year median of 7,682.89 and 6653.6% above the Biotechnology industry median of 113.76. MindMaze Therapeutics Holding's overall GF Score™ is 15/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For MindMaze Therapeutics Holding (CHIX:MMTXZ), the current Days Payable is 7,682.89 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
MindMaze Therapeutics Holding Business Description
MindMaze Therapeutics Holding SA is a Swiss-based, commercial-stage biopharmaceutical and neurotechnology company. The company develops and commercializes digital treatments for neurological diseases and brain disorders. Its technology platform integrates software, sensors, and telehealth, and its solutions are used in clinical and home settings internationally. The company has developed evidence-based, next-generation neurotherapeutics that provide evidence-based motor and cognitive treatments to redefine clinical outcomes in patients with neurological disease and brain disorders. The company also manages Relief's existing portfolio of clinical and commercial biopharmaceutical assets focused on rare dermatological, metabolic, and respiratory diseases.
15GF Score
Get the complete analysis for CHIX:MMTXZ
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CHIX:MMTXZ has been successfully added to your 